Price Alert

BioLife Solutions Inc. (BLFS)

NASDAQ: BLFS · Real-Time Price · USD

25.32

-0.36 (-1.40%)

At close: Aug 14, 2025, 3:59 PM

25.32

0.00%

After-hours: Aug 14, 2025, 04:20 PM EDT

-1.40% (1D)

Bid	24.05
Market Cap	1.21B
Revenue (ttm)	79.42M
Net Income (ttm)	-10.41M
EPS (ttm)	-0.4
PE Ratio (ttm)	-63.3
Forward PE	284
Analyst	Buy

Ask	26.57
Volume	400,561
Avg. Volume (20D)	627,240.6
Open	25.41
Previous Close	25.68
Day's Range	24.70 - 25.71
52-Week Range	19.10 - 29.55
Beta	1.76

About BLFS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol BLFS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for BLFS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

BioLife Solutions has released their quartely earnings on Aug 7, 2025:

Revenue of $25.42M exceeds estimates by $1.69M, with -10.26% YoY decline.

EPS of 0.009 exceeds estimates by 0.02, with 118.00% YoY growth.

Next Earnings Release

BioLife Solutions Inc. is scheduled to release its earnings on Nov 11, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

+9.88%

BioLife Solutions shares are trading higher after ... Unlock content with Pro Subscription

News

1 day ago · zacks.com

4 Medical Product Stocks to Watch From a Challenging Industry

The Zacks Medical products industry sees steady demand, but tariffs & policy headwinds keep growth under pressure in 2025. NVST, BLFS, INFU and MRMD reflect the favorable fundamentals.

3 days ago · zacks.com

BioLife Solutions (BLFS) Upgraded to Strong Buy: Here's Why

BioLife Solutions (BLFS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

2 days ago · zacks.com

Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know

The mean of analysts' price targets for BioLife Solutions (BLFS) points to a 39.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amon...

1 week ago · seekingalpha.com

BioLife Solutions, Inc. (BLFS) Q2 2025 Earnings Call Transcript

BioLife Solutions, Inc. (NASDAQ:BLFS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Roderick de Greef - CEO & Chairman Troy Wichterman - Chief Financial Officer Conf...

1 week ago · zacks.com

BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2

BioLife Solutions, Inc. (BLFS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.06 per share a year ago.

2 months ago · zacks.com

How Much Upside is Left in BioLife Solutions (BLFS)? Wall Street Analysts Think 41.72%

The average of price targets set by Wall Street analysts indicates a potential upside of 41.7% in BioLife Solutions (BLFS). While the effectiveness of this highly sought-after metric is questionable, ...